Scottish government publishes prescribing guidance aiming to save millions of pounds The Scottish government's draft guidance sets out a list of 17 products that are of “low clinical value” and 11 products that are of “limited clinical value”.…
RPS asks for views on facilitated self-selection of P medicines The Society says it wants to hear evidence of the benefits and harms of a facilitated self-selection model for Pharmacy medicines.…
‘Beyond weight loss’: what is the future of semaglutide? As warnings mount around the dangerous accessibility of semaglutide products Wegovy and Ozempic as quick weight loss hacks, researchers are questioning whether the drug has wider implications for other conditions.…
Using data to improve prescribing practice Data analysis is an important tool that prescribers can use to improve outcomes and optimise practice. This article introduces some of the principles, tools and approaches that pharmacists can use.…
Labour Party promises ‘more pharmacists independent prescribing rights’ in manifesto The Labour Party plans to address pressure on GP surgeries by improving access to treatment through new routes, such as through a Community Pharmacy Prescribing Service.…
A flexible approach will make the most of changes to pharmacy education and training As pharmacy training sites prepare to supervise a cohort of trainee prescribing pharmacists, Noma Al-Ahmad shares her view on how to navigate the new requirements.…
Pharmacists to be central in delivery of campaign to cut prescribing of high-risk pain medicines NHS Fife's 'Pain Talking' campaign is aimed at giving patients better control over chronic pain management and promoting non-medical treatment.…
Pregabalin prescribing increases by almost 25% since restrictions imposed Exclusive: Almost 670,000 patients in England were prescribed pregabalin when it was first reclassified in 2018/2019, compared with more than 820,000 patients in 2023/2024.…
‘Unresolvable conflict’: are links to big tobacco changing inhaler prescribing? The takeover of inhaler company Vectura by tobacco firm Philip Morris International has stirred up debate and controversy, with experts raising questions around whether the NHS is doing enough to make the connection clear to prescribers and patients.…
A new way to explore professional skills learning content from The Pharmaceutical Journal Introducing The Pharmaceutical Journal’s newly reorganised collection of professional skills articles responding to the changing learning requirements of the pharmacy profession.…
